Login
← Go Back
Concord Biotech
CONCORDBIO · Pharma > Pharmaceuticals & Drugs Listing date: Aug. 18, 2023
Stock Price vs Company Growth
1d
2.4%
1w
2.3%
1m
7.6%
3m
10.9%
6m
41.4%
all
71.9%
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 1,619 2.4%
1,350
1,712
Company Overview
Sales
939 Cr
Growth: 24.6%
Profit after Tax
290 Cr
Growth: 23.7%
Mid Cap
16,935 Cr
P/E: 58.3x
Industry P/E: 35.0x
Fundamentals
Sales (Cr) ₹ 939
Growth 24.6%
EBITDA 43.6%
P/S 18.0x
Dividend 0.0%
P/E 58.3x
Book Value ₹ 1
PEG Ratio 2.4x
ROE 999.0%
P/B N/A
Shareholding Pattern
Increase    Decrease    No change
Company Profile Detailed
The company is an India-based biopharma company and one of the leading global developers and manufacturers of select fermentation-based APIs across Immunosuppressants and oncology.
Belongs to (10 Indices) view more